U.S. Markets open in 7 hrs 38 mins

Recent Analysis Shows Coca-Cola, Neurocrine Biosciences, Worthington Industries, Lennox International, Barrett Business Services, and Balchem Market Influences — Renewed Outlook, Key Drivers of Growth

NEW YORK, April 01, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Coca-Cola Company (KO), Neurocrine Biosciences, Inc. (NBIX), Worthington Industries, Inc. (WOR), Lennox International, Inc. (LII), Barrett Business Services, Inc. (BBSI), and Balchem Corporation (BCPC), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

KO DOWNLOAD: http://MarketSourceResearch.com/register/?so=KO
NBIX DOWNLOAD: http://MarketSourceResearch.com/register/?so=NBIX
WOR DOWNLOAD: http://MarketSourceResearch.com/register/?so=WOR
LII DOWNLOAD: http://MarketSourceResearch.com/register/?so=LII
BBSI DOWNLOAD: http://MarketSourceResearch.com/register/?so=BBSI
BCPC DOWNLOAD: http://MarketSourceResearch.com/register/?so=BCPC

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Market Source Research, available for free download at the links above, examine Coca-Cola Company (KO), Neurocrine Biosciences, Inc. (NBIX), Worthington Industries, Inc. (WOR), Lennox International, Inc. (LII), Barrett Business Services, Inc. (BBSI), and Balchem Corporation (BCPC) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed March 28th, 2019. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

COCA-COLA COMPANY (KO) REPORT OVERVIEW

Coca-Cola's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Coca-Cola reported revenue of $7,058.00MM vs $7,512.00MM (down 6.04%) and analysts estimated basic earnings per share $0.21 vs -$0.65. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Coca-Cola reported revenue of $31,856.00MM vs $35,410.00MM (down 10.04%) and analysts estimated basic earnings per share $1.51 vs $0.29 (up 420.69%). Analysts expect earnings to be released on April 23rd, 2019. The report will be for the fiscal period ending March 31st, 2019. Based on 8 analysts' forecasts, the consensus EPS forecast for the quarter is $0.43. The reported EPS for the same quarter last year was $0.47. The estimated EPS forecast for the next fiscal year is $2.27 and is expected to report on February 13th, 2020.

To read the full Coca-Cola Company (KO) report, download it here: http://MarketSourceResearch.com/register/?so=KO

-----------------------------------------

NEUROCRINE BIOSCIENCES, INC. (NBIX) REPORT OVERVIEW

Neurocrine Biosciences' Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Neurocrine Biosciences reported revenue of $131.49MM vs $94.52MM (up 39.12%) and analysts estimated basic earnings per share $0.21 vs $0.09 (up 133.33%). For the twelve months ended December 31st, 2018 vs December 31st, 2017, Neurocrine Biosciences reported revenue of $451.24MM vs $161.63MM (up 179.19%) and analysts estimated basic earnings per share $0.23 vs -$1.62. Analysts expect earnings to be released on April 29th, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was -$0.47. The estimated EPS forecast for the next fiscal year is $3.11 and is expected to report on February 4th, 2020.

To read the full Neurocrine Biosciences, Inc. (NBIX) report, download it here: http://MarketSourceResearch.com/register/?so=NBIX

-----------------------------------------

WORTHINGTON INDUSTRIES, INC. (WOR) REPORT OVERVIEW

Worthington Industries' Recent Financial Performance

For the three months ended November 30th, 2018 vs November 30th, 2017, Worthington Industries reported revenue of $958.23MM vs $871.27MM (up 9.98%) and analysts estimated basic earnings per share $0.59 vs $0.64 (down 7.81%). For the twelve months ended May 31st, 2018 vs May 31st, 2017, Worthington Industries reported revenue of $3,581.62MM vs $3,014.11MM (up 18.83%) and analysts estimated basic earnings per share $3.20 vs $3.28 (down 2.44%). Analysts expect earnings to be released on June 26th, 2019. The report will be for the fiscal period ending May 31st, 2019. Reported EPS for the same quarter last year was $0.95. The estimated EPS forecast for the next fiscal year is $3.25 and is expected to report on June 26th, 2019.

To read the full Worthington Industries, Inc. (WOR) report, download it here: http://MarketSourceResearch.com/register/?so=WOR

-----------------------------------------

LENNOX INTERNATIONAL, INC. (LII) REPORT OVERVIEW

Lennox International's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Lennox International reported revenue of $843.50MM vs $891.80MM (down 5.42%) and basic earnings per share $1.87 vs $1.03 (up 81.55%). For the twelve months ended December 31st, 2018 vs December 31st, 2017, Lennox International reported revenue of $3,883.90MM vs $3,839.60MM (up 1.15%) and analysts estimated basic earnings per share $8.84 vs $7.25 (up 21.93%). Analysts expect earnings to be released on April 22nd, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $1.13. The estimated EPS forecast for the next fiscal year is $12.77 and is expected to report on February 4th, 2020.

To read the full Lennox International, Inc. (LII) report, download it here: http://MarketSourceResearch.com/register/?so=LII

-----------------------------------------

BARRETT BUSINESS SERVICES, INC. (BBSI) REPORT OVERVIEW

Barrett Business Services' Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Barrett Business Services reported revenue of $237.83MM vs $244.73MM (down 2.82%) and analysts estimated basic earnings per share $2.30 vs $1.45 (up 58.62%). For the twelve months ended December 31st, 2018 vs December 31st, 2017, Barrett Business Services reported revenue of $940.70MM vs $920.43MM (up 2.20%) and analysts estimated basic earnings per share $5.18 vs $3.46 (up 49.71%). Analysts expect earnings to be released on May 7th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was -$1.25.

To read the full Barrett Business Services, Inc. (BBSI) report, download it here: http://MarketSourceResearch.com/register/?so=BBSI

-----------------------------------------

BALCHEM CORPORATION (BCPC) REPORT OVERVIEW

Balchem's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Balchem reported revenue of $163.54MM vs $159.26MM (up 2.68%) and analysts estimated basic earnings per share $0.64 vs $1.32 (down 51.52%). For the twelve months ended December 31st, 2018 vs December 31st, 2017, Balchem reported revenue of $643.68MM vs $594.79MM (up 8.22%) and analysts estimated basic earnings per share $2.45 vs $2.83 (down 13.43%). Analysts expect earnings to be released on May 3rd, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.76. The estimated EPS forecast for the next fiscal year is $3.45 and is expected to report on February 27th, 2020.

To read the full Balchem Corporation (BCPC) report, download it here: http://MarketSourceResearch.com/register/?so=BCPC

-----------------------------------------

ABOUT MARKET SOURCE RESEARCH

Market Source Research delivers the key research reports that helps serious investors, registered brokers, professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA® BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content that's ahead of the curve. With insights on individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well as granular detail.

REGISTERED MEMBER STATUS

Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by E-mail at compliance@MarketSourceResearch.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Jim Patterson, Media Department
Office: +1 (704) 343-6361
E-mail: media@MarketSourceResearch.com

© 2019 Market Source Research. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@MarketSourceResearch.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.